Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Connective tissue remodelling is differently modulated by tocilizumab versus methotrexate monotherapy in patients with early rheumatoid arthritis: the AMBITION study

Fig. 2

Figures represent differences in modulation of tissue remodelling biomarkers C1M (a) (TCZ n = 115; MTX n = 128; PBO n = 49), C2M (b) (TCZ n = 109; MTX n = 122; PBO n = 36), C3M (c) (TCZ n = 141; MTX n = 145; PBO n = 47), C4M (d) (TCZ n = 140; MTX n = 146; PBO n = 46), CRPM (e) (TCZ n = 143; MTX n = 145; PBO n = 48) and CRP (f) (TCZ n = 164; MTX n = 161; PBO n = 53) according to treatment from baseline to week 8 (%). Data are shown as mean with CI-95%

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us